Camelina plants could produce aviation fuel in future
U of M Researcher Matthew Ott explains scientists are trying to use camelina plants as aviation fuel.
The seeds can be refined into cooking oil, and then further refined into sustainable aviation fuel.
'We're early in the process, but we're scaling up,' Mr Ott said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
9 News
3 hours ago
- 9 News
Revolutionary late-stage melanoma treatment sees survival rates surge
Your web browser is no longer supported. To improve your experience update it here A revolution in the treatment of late-stage melanoma has been reached, with clinical trial results seeing surging survival rates. Doctors are confident the new therapy approach, which will be subsidised by the Pharmaceutical Benefits Scheme (PBS), will overhaul the treatment of many types of deadly cancers. A tumour the size of a golf ball saw death come knocking for Matthew Croxford. A revolution in the treatment of late-stage melanoma has been reached with clinical trial results seeing surging survival rates (Nine) "You think - is this it?" the 52-year-old father-of-two told 9News. "And I had a lot of things to still achieve in my life." Croxford was offered to take part in an Australian and Netherlands-driven trial. The new therapy has flipped the cancer paradigm on its head, by giving the body the best opportunity to activate its own cancer-fighting defences. "It's like the sniffer dogs that find the fruit and veg and drugs at the airport, they're trained against what they need to find," The Melanoma Institute's Professor Georgina Long said. "By giving immunotherapy before surgery, we train our immune system better against the cancer," she said. A new therapy has flipped the cancer paradigm on its head by giving the body the best opportunity to activate its own cancer-fighting defences. (Nine) Of the 423 patients with Stage 3 melanoma, one group received usual treatment with surgery first, then a single immunotherapy drug. That order was then flipped for the other group, who were given two immunotherapy drugs first to shrink the tumour before surgery. "Their chance of the melanoma coming back is next to zero - it's less than five per cent," Long said. Such revolutionary results have seen the treatment approved to be funded by the PBS - a world first. Matthew Croxford was offered to take part in an Australian and Netherlands-driven trial. (Nine) Australia has the highest rates of melanoma in the world, with one person diagnosed every 30 minutes and a life lost every six hours because of the disease. Advances in treatment like this shift a diagnosis that has often been a death sentence to promising odds of survival. "I'm effectively cancer-free, I have no side effects whatsoever, and I'm incredibly fortunate," Croxford said. "It's like the sniffer dogs that find the fruit and veg and drugs at the airport, they're trained against what they need to find," The Melanoma Institute's Professor Georgina Long said. (Nine) The radical overhaul of traditional treatment is now being explored for other cancers, including lung, triple-negative breast cancer, kidney, head and neck cancers. This new treatment for Stage 3 melanoma patients is to be listed on the PBS within months. national cancer health melanoma medicine PBS CONTACT US Property News: The last inner Sydney suburbs where houses cost under $2m.
Sky News AU
3 hours ago
- Sky News AU
Studies at Casey Research Station in Antarctica ‘more critical now than' ever
Casey Research Station Leader Andy Warton says the research at Casey Research Station and other Australian Antarctic stations is 'more critical now than it's ever been'. 'It's more critical now than it's ever been,' Mr Warton told Sky News Australia. 'The work that goes on, not just at this station, but at other Australian stations … it's absolutely critical work. 'We keep the stations alive.'
Sydney Morning Herald
3 hours ago
- Sydney Morning Herald
‘A bomb thrown into the middle of science': Trump cuts hurt Australian medical research
Australian medical research institutes are suspending projects on malaria, tuberculosis and women's health, as well as laying off staff, as they reel from the Trump administration's multibillion-dollar science cuts. The situation has drawn condemnation from Australian scientists. Burnet Institute director Professor Brendan Crabb likened the cuts to 'having a bomb thrown into the middle of science'. 'The world of science and research in all its forms … is undergoing a global seismic shift as a result of what the US is doing,' he said. 'I can't think of another circumstance since the end of World War II where things have been upended so profoundly.' Preliminary estimates from the Burnet Institute show that the US cuts have left a $1.2 million funding shortfall across the organisation's global health programs and collaborations. A spokeswoman said this had led to the suspension until 2030 of research projects involving malaria, harm reduction, tuberculosis and women's and children's health. Loading Professor James Beeson, a world-renowned malaria researcher from the Burnet Institute, said the cuts would put millions of lives at risk. Beeson pointed to research by the Malaria Atlas Project, which estimates that a complete freeze in US funding would lead to 15 million additional cases of malaria every year and 107,000 deaths. Maternal deaths, stillbirths, tuberculosis and HIV rates throughout the Asia-Pacific region and parts of Africa would also increase substantially over the next few years unless the funding cuts were reversed or replaced by other funding sources, he said.
